ClinicalTrials.govpublic full text
Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm
parkinson disease, gait, balance, gaba, transdermal flumazenil (previously clarithromycin changed 4/2020), pet imaging, mri, mobility, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 887102
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.